{"gene":"GPS1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1998,"finding":"GPS1 (also called CSN1/Trip15) was identified as a subunit of a novel ~450 kDa human protein complex (the COP9 signalosome/JAB1-containing signalosome) that possesses associated kinase activity capable of phosphorylating IκBα, the C-terminus of p105, and Ser63/Ser73 of c-Jun. The complex contains homologs of plant COP9 and COP11, and GPS1 (Trip15) was identified as one of eight subunits with sequence similarity to 26S proteasome regulatory components.","method":"Biochemical purification from human cells, kinase activity assays, sequence analysis","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 — original purification and biochemical characterization of the complex, replicated and foundational","pmids":["9535219"],"is_preprint":false},{"year":2001,"finding":"The COP9 signalosome (CSN), of which GPS1/CSN1 is a core subunit, promotes cleavage of the ubiquitin-like protein NEDD8 from CUL1 both in vivo and in vitro. CSN-deficient S. pombe cells accumulate multiple NEDD8-modified proteins, placing the CSN complex as a broad deneddylase for cullin-based SCF ubiquitin ligases.","method":"In vitro NEDD8 cleavage assay, in vivo analysis of CSN-deficient S. pombe, co-purification with human SCF component CUL1","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of deneddylation activity, genetic loss-of-function confirmation, foundational mechanistic paper","pmids":["11337588"],"is_preprint":false},{"year":2001,"finding":"The COP9 signalosome (CSN), containing GPS1/CSN1, specifically phosphorylates p53 at Thr155 in its core domain, targeting p53 for ubiquitin-26S proteasome-dependent degradation. p53 binds with high affinity to the native CSN complex via its N-terminus interacting with CSN5/JAB1. Mutation of Thr155 to valine stabilizes p53 against E6-dependent degradation and reduces Mdm2 binding. The CSN kinase inhibitor curcumin blocks E6-dependent p53 degradation.","method":"Electron microscopy of p53-CSN complex, far-western and pull-down assays, phosphorylation site mapping, mutagenesis (T155V), cell-based degradation assays, curcumin inhibitor studies","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis, structural visualization, and functional rescue in cells","pmids":["11285227"],"is_preprint":false},{"year":2002,"finding":"GPS1/CSN1 is a binding partner of inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase), which associates with the COP9 signalosome through direct interaction with CSN1. The 5/6-kinase was identified as the previously uncharacterized COP9-associated kinase activity: it phosphorylates the same substrates as the CSN-associated kinase (IκBα, p53, c-Jun) and is inhibited by curcumin. Association with CSN1 inhibits the inositol kinase activity of 5/6-kinase.","method":"Purification from bovine brain, co-immunoprecipitation in HEK293 cells, substrate phosphorylation assays, curcumin inhibition assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, biochemical assays with multiple substrates, replicated in two systems (bovine brain and transfected cells)","pmids":["12324474"],"is_preprint":false},{"year":2003,"finding":"The COP9 signalosome (CSN), containing GPS1/CSN1, is incorporated into DDB2 and CSA ubiquitin ligase complexes (both containing cullin 4A and Roc1) and differentially regulates their ubiquitin ligase activity in response to UV irradiation. CSN knockdown via RNAi leads to defects in nucleotide excision repair (NER), placing GPS1's complex as a regulator of NER through control of cullin-based E3 ligase activity.","method":"Biochemical purification of DDB2 and CSA complexes, ubiquitin ligase activity assays, RNA interference knockdown with NER functional readout","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical reconstitution of ligase activity, RNAi loss-of-function with defined NER phenotype, high-citation foundational paper","pmids":["12732143"],"is_preprint":false},{"year":2007,"finding":"GPS1/CSN1 was identified as a binding partner of Asb-4 (ankyrin repeat and SOCS box containing protein 4) by yeast two-hybrid screening. GPS1 co-immunoprecipitates with Asb-4 in vitro and in HEK293 cells. Co-expression of Asb-4 reduces GPS1 protein levels independently of the SOCS box domain. GPS1 enhances JNK activity and potentiates insulin-stimulated JNK activation and IRS-1 Ser307 phosphorylation; co-expression of Asb-4 with GPS1 inhibits JNK activity and reduces IRS-1 Ser307 phosphorylation.","method":"Yeast two-hybrid screen, co-immunoprecipitation (in vitro and in HEK293 cells), kinase activity assays, co-transfection experiments in NIH 3T3-L1 and HEK293 cells","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2-3 — Y2H confirmed by co-IP, functional kinase readout, but single lab study","pmids":["17276034"],"is_preprint":false},{"year":2011,"finding":"GPS1/CSN1 inhibits phosphorylation of proto-oncogene c-Jun and represses c-Jun-dependent transcription. Furthermore, CSN1 dramatically downregulates ectopic JNK1 expression in cultured cells through repression at transcriptional and/or posttranscriptional steps (not through excessive proteolysis or 3'UTR-dependent mRNA instability). This places GPS1/CSN1 as a negative regulator of the AP-1 pathway, in contrast to CSN5/JAB1 which promotes AP-1 activity.","method":"Phosphorylation assays of c-Jun, transcriptional reporter assays, western blotting, mRNA stability analysis, cell-based overexpression experiments","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple assays in cultured cells, single lab, mechanistic follow-up confirmed by exclusion of alternative mechanisms","pmids":["21604193"],"is_preprint":false},{"year":2016,"finding":"Somatic missense mutations in GPS1 (CSN1) were identified in penile squamous cell carcinoma. Expression of GPS1 mutants in cells resulted in colocalization with AGO2 in cytoplasmic P-bodies and loss of miRNA-mediated gene silencing, suggesting a tumor suppressor role for GPS1 in this cancer type through regulation of the miRNA/RISC pathway.","method":"Whole-exome sequencing, targeted resequencing, cell-based functional assays with mutant GPS1 constructs, colocalization imaging with AGO2","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2-3 — exome sequencing plus functional cell-based validation with defined molecular readout (AGO2 colocalization, miRNA silencing), single study","pmids":["27325650"],"is_preprint":false},{"year":2020,"finding":"GPS1/CSN1 physically interacts with NSMCE4A, the kleisin subunit of the SMC5/6 complex, linking the COP9 signalosome to the SMC5/6 genome maintenance complex. GPS1 and SMC5/6 components colocalize during interphase and mitosis. Depletion of GPS1 (which negatively impacts DNA end resection during homologous recombination repair) causes increased SMC5/6 accumulation at sites of laser-induced DNA damage. Inhibition of CSN deneddylation activity similarly increases SMC5/6 at DNA damage sites.","method":"Yeast two-hybrid screen, co-immunoprecipitation, colocalization imaging during cell cycle, GPS1 depletion with laser-induced DNA damage assay, CSN inhibition experiments","journal":"BMC molecular and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — Y2H confirmed by co-IP, functional loss-of-function with DNA damage readout, multiple approaches in single study","pmids":["32384871"],"is_preprint":false},{"year":2020,"finding":"GPS1/CSN1 knockdown in hepatocellular carcinoma cells inhibits cell proliferation and migration. GPS1 promotes expression of cyclin A2 in a ubiquitination-independent manner. In vivo xenograft experiments confirmed GPS1 promotes HCC tumor growth.","method":"siRNA knockdown, proliferation and migration assays, cyclin A2 expression analysis, xenograft tumor model","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss-of-function with defined cellular and molecular phenotype, in vivo validation, single lab","pmids":["33200803"],"is_preprint":false},{"year":2024,"finding":"GPS1 protein is asymmetrically distributed between alpha and beta blastomeres of 2-cell mouse and human embryos. Depletion or overexpression of GPS1 in one blastomere of the 2-cell mouse embryo impacts lineage segregation toward epiblast versus trophectoderm/primitive endoderm fates, demonstrating a functional role for GPS1 in early mammalian embryo cell fate determination.","method":"Single-cell proteomics (multiplexed and label-free mass spectrometry), GPS1 depletion/overexpression in individual blastomeres with lineage fate tracking","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 — single-cell proteomics plus functional perturbation with lineage readout, preprint not yet peer-reviewed","pmids":["bio_10.1101_2024.08.26.609777"],"is_preprint":true}],"current_model":"GPS1 (CSN1) is a core subunit of the eight-subunit COP9 signalosome (CSN) that functions as a deneddylase for cullin-RING ubiquitin ligases (removing NEDD8 from cullins), associates with an inositol trisphosphate 5/6-kinase that phosphorylates substrates including IκBα, p53 (at Thr155, targeting it for proteasomal degradation), and c-Jun, negatively regulates the AP-1/JNK pathway by suppressing c-Jun phosphorylation and JNK1 expression, interacts with the SMC5/6 complex via NSMCE4A to coordinate homologous recombination repair, and in early mammalian embryos is asymmetrically distributed between blastomeres where its levels influence lineage segregation."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of GPS1 as a subunit of the COP9 signalosome established that a ~450 kDa complex distinct from the 26S proteasome harbors associated kinase activity toward IκBα, p105, and c-Jun, opening the question of what enzymatic activities this complex carries.","evidence":"Biochemical purification from human cells with kinase assays and sequence analysis","pmids":["9535219"],"confidence":"High","gaps":["Identity of the CSN-associated kinase was unknown","Physiological substrates of the complex not validated in vivo","Stoichiometry and architecture of GPS1 within the complex unresolved"]},{"year":2001,"claim":"Discovery that the CSN is a deneddylase that cleaves NEDD8 from cullins revealed the primary enzymatic activity of the GPS1-containing complex and explained its role in regulating SCF ubiquitin ligase cycles.","evidence":"In vitro NEDD8 cleavage assay plus analysis of CSN-deficient S. pombe showing accumulation of neddylated proteins","pmids":["11337588"],"confidence":"High","gaps":["Contribution of individual subunits including GPS1 to deneddylation catalysis not dissected","Scope of cullin substrates beyond CUL1 not fully mapped"]},{"year":2001,"claim":"Demonstration that the CSN phosphorylates p53 at Thr155 to promote its ubiquitin-dependent degradation connected the GPS1-containing complex to a major tumor suppressor pathway and distinguished the CSN kinase from known p53 kinases.","evidence":"Phosphorylation site mapping, T155V mutagenesis stabilizing p53, electron microscopy of p53–CSN complex, curcumin inhibition of degradation","pmids":["11285227"],"confidence":"High","gaps":["Molecular identity of the responsible kinase still unresolved at this point","In vivo relevance of Thr155 phosphorylation in tumor settings not tested"]},{"year":2002,"claim":"Identification of inositol 1,3,4-trisphosphate 5/6-kinase as the CSN-associated kinase, recruited through direct binding to GPS1, resolved the long-standing question of the kinase's identity and revealed GPS1 as a scaffold bridging kinase and deneddylase activities.","evidence":"Purification from bovine brain, reciprocal co-IP in HEK293 cells, substrate phosphorylation assays matching CSN kinase specificity, curcumin sensitivity","pmids":["12324474"],"confidence":"High","gaps":["Structural basis of GPS1–5/6-kinase interaction not determined","How GPS1 binding inhibits inositol kinase activity mechanistically unclear"]},{"year":2003,"claim":"Showing that the CSN is incorporated into CUL4A-based DDB2 and CSA ubiquitin ligase complexes and that CSN knockdown impairs nucleotide excision repair extended GPS1's functional reach from SCF regulation to the DNA damage response.","evidence":"Biochemical purification of DDB2/CSA ligase complexes, ubiquitin ligase activity assays, RNAi knockdown with NER phenotype","pmids":["12732143"],"confidence":"High","gaps":["Whether GPS1 subunit specifically contacts CUL4A ligase components not resolved","Relative contributions of deneddylation versus kinase activity to NER unclear"]},{"year":2007,"claim":"Discovery that Asb-4 binds GPS1 and reduces its protein levels, thereby attenuating GPS1-enhanced JNK activity and IRS-1 Ser307 phosphorylation, placed GPS1 at an intersection of JNK and insulin signaling.","evidence":"Yeast two-hybrid confirmed by co-IP, kinase assays and co-transfection in HEK293/3T3-L1 cells","pmids":["17276034"],"confidence":"Medium","gaps":["Mechanism by which Asb-4 reduces GPS1 levels (proteasomal vs. transcriptional) not defined","Physiological relevance in metabolic tissues not demonstrated in vivo"]},{"year":2011,"claim":"Establishing GPS1 as a negative regulator of c-Jun phosphorylation and JNK1 expression clarified its role opposing CSN5-mediated AP-1 activation, revealing subunit-specific signaling polarity within the CSN.","evidence":"Phosphorylation and transcriptional reporter assays, JNK1 expression analysis ruling out proteolysis and mRNA instability","pmids":["21604193"],"confidence":"Medium","gaps":["Mechanism of JNK1 transcriptional/posttranscriptional repression by GPS1 not identified","Whether this function requires intact CSN or is a moonlighting role is unclear"]},{"year":2016,"claim":"Identification of somatic GPS1 mutations in penile squamous cell carcinoma that cause AGO2 mislocalization and loss of miRNA silencing expanded GPS1's functional repertoire to include regulation of the RISC pathway.","evidence":"Whole-exome sequencing with targeted resequencing, cell-based expression of mutant GPS1 with AGO2 colocalization and miRNA silencing readouts","pmids":["27325650"],"confidence":"Medium","gaps":["Direct physical interaction between GPS1 and AGO2/RISC components not demonstrated","Whether miRNA silencing defect is CSN-dependent or GPS1-autonomous unknown","Single tumor type studied; generality of tumor suppressor role unclear"]},{"year":2020,"claim":"Demonstration that GPS1 physically interacts with NSMCE4A and that GPS1 depletion or CSN inhibition causes excess SMC5/6 accumulation at DNA damage sites linked the CSN to homologous recombination repair through the SMC5/6 genome maintenance complex.","evidence":"Yeast two-hybrid confirmed by co-IP, colocalization imaging across cell cycle, GPS1 depletion with laser-induced damage and CSN inhibition","pmids":["32384871"],"confidence":"Medium","gaps":["Whether GPS1–NSMCE4A interaction requires intact CSN or occurs independently not resolved","Which cullin-RING ligase is the deneddylation target relevant to SMC5/6 recruitment unknown"]},{"year":2020,"claim":"GPS1 knockdown in hepatocellular carcinoma cells inhibited proliferation and migration, with GPS1 promoting cyclin A2 expression independently of ubiquitination, revealing a pro-tumorigenic role in HCC that contrasts with its tumor suppressor function in penile SCC.","evidence":"siRNA knockdown, proliferation/migration assays, cyclin A2 expression analysis, in vivo xenograft validation","pmids":["33200803"],"confidence":"Medium","gaps":["Mechanism by which GPS1 upregulates cyclin A2 in a ubiquitination-independent manner not defined","Context-dependent oncogenic versus tumor-suppressive roles not reconciled"]},{"year":null,"claim":"Key unresolved questions include the structural basis by which GPS1 scaffolds kinase and deneddylase activities within the CSN, whether GPS1's roles in miRNA silencing and AP-1/JNK regulation are CSN-dependent or moonlighting functions, and the mechanism underlying context-dependent oncogenic versus tumor-suppressive activities across cancer types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of GPS1 within a full CSN complex with bound kinase","CSN-dependent versus CSN-independent functions of GPS1 not systematically dissected","In vivo genetic models (knockout mouse) characterizing GPS1 function in development and disease are lacking in the timeline"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,7]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,2,4]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4,8]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,6]}],"complexes":["COP9 signalosome (CSN)"],"partners":["CSN5","ITPK1","NSMCE4A","ASB4","CUL1","AGO2","TP53"],"other_free_text":[]},"mechanistic_narrative":"GPS1 (CSN1) is a core subunit of the eight-subunit COP9 signalosome (CSN), a conserved complex that functions as a deneddylase removing NEDD8 from cullins to regulate cullin-RING ubiquitin ligase activity, thereby controlling protein ubiquitination in pathways including nucleotide excision repair and p53 degradation [PMID:11337588, PMID:12732143, PMID:11285227]. GPS1 directly recruits inositol 1,3,4-trisphosphate 5/6-kinase to the CSN, providing an associated kinase activity that phosphorylates IκBα, p53 (at Thr155), and c-Jun [PMID:12324474, PMID:9535219]. Independent of CSN deneddylase activity, GPS1 negatively regulates the AP-1/JNK signaling axis by suppressing c-Jun phosphorylation and JNK1 expression, and interacts with the SMC5/6 complex component NSMCE4A to coordinate DNA end resection during homologous recombination repair [PMID:21604193, PMID:32384871]. Somatic missense mutations in GPS1 in penile squamous cell carcinoma disrupt miRNA-mediated gene silencing through aberrant AGO2 colocalization, implicating GPS1 as a tumor suppressor [PMID:27325650]."},"prefetch_data":{"uniprot":{"accession":"Q13098","full_name":"COP9 signalosome complex subunit 1","aliases":["G protein pathway suppressor 1","GPS-1","JAB1-containing signalosome subunit 1","Protein MFH"],"length_aa":491,"mass_kda":55.5,"function":"Essential component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. Suppresses G-protein- and mitogen-activated protein kinase-mediated signal transduction","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13098/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/GPS1","classification":"Common Essential","n_dependent_lines":1188,"n_total_lines":1208,"dependency_fraction":0.9834437086092715},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DDB1","stoichiometry":0.2},{"gene":"GDI2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GPS1","total_profiled":1310},"omim":[{"mim_id":"616008","title":"COP9 SIGNALOSOME, SUBUNIT 4; COPS4","url":"https://www.omim.org/entry/616008"},{"mim_id":"604850","title":"COP9 SIGNALOSOME, SUBUNIT 5; COPS5","url":"https://www.omim.org/entry/604850"},{"mim_id":"604665","title":"COP9 SIGNALOSOME, SUBUNIT 3; COPS3","url":"https://www.omim.org/entry/604665"},{"mim_id":"604508","title":"COP9 SIGNALOSOME, SUBUNIT 2; COPS2","url":"https://www.omim.org/entry/604508"},{"mim_id":"603134","title":"CULLIN 1; CUL1","url":"https://www.omim.org/entry/603134"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GPS1"},"hgnc":{"alias_symbol":["COPS1","CSN1"],"prev_symbol":[]},"alphafold":{"accession":"Q13098","domains":[{"cath_id":"1.10.10","chopping":"383-453","consensus_level":"medium","plddt":92.851,"start":383,"end":453}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13098","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13098-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13098-F1-predicted_aligned_error_v6.png","plddt_mean":84.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPS1","jax_strain_url":"https://www.jax.org/strain/search?query=GPS1"},"sequence":{"accession":"Q13098","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13098.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13098/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13098"}},"corpus_meta":[{"pmid":"12324474","id":"PMC_12324474","title":"Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12324474","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11854419","id":"PMC_11854419","title":"CSN1 N-terminal-dependent activity is required for Arabidopsis development but not for Rub1/Nedd8 deconjugation of cullins: a structure-function study of CSN1 subunit of COP9 signalosome.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11854419","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27325650","id":"PMC_27325650","title":"CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27325650","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19175768","id":"PMC_19175768","title":"Regulation of COP1 nuclear localization by the COP9 signalosome via direct interaction with CSN1.","date":"2009","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19175768","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17276034","id":"PMC_17276034","title":"Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.","date":"2007","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/17276034","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22133685","id":"PMC_22133685","title":"TSA1 interacts with CSN1/CSN and may be functionally involved in Arabidopsis seedling development in darkness.","date":"2011","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/22133685","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33200803","id":"PMC_33200803","title":"CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33200803","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23284057","id":"PMC_23284057","title":"Gravity Persistent Signal 1 (GPS1) reveals novel cytochrome P450s involved in gravitropism.","date":"2013","source":"American journal of botany","url":"https://pubmed.ncbi.nlm.nih.gov/23284057","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21604193","id":"PMC_21604193","title":"CSN1 inhibits c-Jun phosphorylation and down-regulates ectopic expression of JNK1.","date":"2011","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/21604193","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32384871","id":"PMC_32384871","title":"Interaction between NSMCE4A and GPS1 links the SMC5/6 complex to the COP9 signalosome.","date":"2020","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32384871","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28148650","id":"PMC_28148650","title":"The septin-associated kinase Gin4 recruits Gps1 to the site of cell division.","date":"2017","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28148650","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33555481","id":"PMC_33555481","title":"SAP130 and CSN1 interact and regulate male gametogenesis in Arabidopsis thaliana.","date":"2021","source":"Journal of plant research","url":"https://pubmed.ncbi.nlm.nih.gov/33555481","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16231734","id":"PMC_16231734","title":"[The effect of CSN1 S2, CSN3 and beta-lg genes on milk performance in Xinong Saanen dairy goat].","date":"2005","source":"Yi chuan xue bao = Acta genetica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/16231734","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16088957","id":"PMC_16088957","title":"Interactions between the rabbit CSN1 gene and the nuclear matrix of stably transfected HC11 mammary epithelial cells vary with its level of expression.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16088957","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40141320","id":"PMC_40141320","title":"Effects of CSN1/CSN2 Mutants in Flavonoid Metabolism on Rice (Oryza sativa L.).","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40141320","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41828674","id":"PMC_41828674","title":"GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma Pathogenesis.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41828674","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41788794","id":"PMC_41788794","title":"In vitro digestion and fermentation of ginseng pectic polysaccharide GPS-1 and attenuation of its product on oleic acid-induced oxidative stress in HepG2 cells.","date":"2026","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41788794","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.17.676758","title":"Proteomic and Kinetic Characterization of Prion Seeding in Distinct Human CJD Strains Unveils Early Diagnostic Biomarkers","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.676758","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.08.26.609777","title":"Proteome asymmetry in mouse and human embryos before fate specification","date":"2024-08-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.26.609777","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24292625","id":"PMC_24292625","title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24292625","citation_count":1480,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12732143","id":"PMC_12732143","title":"The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12732143","citation_count":601,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11337588","id":"PMC_11337588","title":"Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11337588","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16949367","id":"PMC_16949367","title":"A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.","date":"2006","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16949367","citation_count":538,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11285227","id":"PMC_11285227","title":"COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11285227","citation_count":314,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9535219","id":"PMC_9535219","title":"A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits.","date":"1998","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/9535219","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17079684","id":"PMC_17079684","title":"DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17079684","citation_count":287,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21903422","id":"PMC_21903422","title":"Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21903422","citation_count":286,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11238,"output_tokens":1952,"usd":0.031497},"stage2":{"model":"claude-opus-4-6","input_tokens":5223,"output_tokens":1902,"usd":0.110497},"total_usd":0.372988,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":22506,"output_tokens":4882,"usd":0.070374},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6816,"output_tokens":2920,"usd":0.16062}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) was identified as the protein kinase activity associated with the COP9 signalosome (CSN); it associates with the eight-component CSN complex via direct binding to CSN1 (GPS1), phosphorylates CSN substrates including IκBα, p53, and c-Jun, and its inositol kinase activity is inhibited when in complex with CSN1.\",\n      \"method\": \"Co-immunoprecipitation from bovine brain and HEK293 cells; in vitro kinase assays; substrate phosphorylation assays; inhibitor studies (curcumin)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (co-IP, in vitro kinase assay, substrate profiling, inhibitor) in a single rigorous study\",\n      \"pmids\": [\"12324474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GPS1 (CSN1) interacts with Asb-4 both in vitro and in HEK293 cells; co-expression of Asb-4 reduces GPS1 protein levels and inhibits GPS1-enhanced JNK activity, while GPS1 expression alone enhances JNK activity and elevates IRS-1 serine 307 phosphorylation in response to insulin.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation in vitro and in HEK293 cells; JNK activity assays; IRS-1 phosphorylation western blotting; overexpression/co-expression experiments in NIH 3T3-L1 and HEK293 cells\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal co-IP plus functional kinase/phosphorylation assays from a single lab\",\n      \"pmids\": [\"17276034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CSN1 (GPS1) inhibits phosphorylation of c-Jun and represses c-Jun-dependent transcription; it also dramatically downregulates ectopic JNK1 expression through transcriptional and post-transcriptional mechanisms (not via proteolysis or 3′-UTR mRNA instability), placing CSN1 as a negative regulator of the AP-1 pathway.\",\n      \"method\": \"Overexpression and knockdown in cultured cells; c-Jun phosphorylation western blotting; reporter gene assays; mRNA stability and proteasome inhibitor experiments\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional assays from a single lab with mechanistic follow-up ruling out alternative mechanisms\",\n      \"pmids\": [\"21604193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GPS1 (CSN1) physically interacts with NSMCE4A, the kleisin subunit of the SMC5/6 complex, linking the COP9 signalosome to the SMC5/6 complex; GPS1 and SMC5/6 components colocalize during interphase and mitosis, and depletion of GPS1 increases SMC5/6 levels at sites of laser-induced DNA damage, implicating CSN-mediated deneddylation in regulation of SMC5/6 during DNA repair.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation; immunofluorescence colocalization; laser-induced DNA damage assay with siRNA depletion; CSN deneddylase inhibitor treatment\",\n      \"journal\": \"BMC molecular and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus functional localization experiments, single lab\",\n      \"pmids\": [\"32384871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GPS1 (CSN1) somatic missense mutations in penile squamous cell carcinoma result in colocalization of mutant GPS1 with AGO2 in cytoplasmic P-bodies and loss of miRNA-mediated gene silencing, identifying GPS1 as a functional component of the miRNA silencing pathway whose loss contributes to oncogenesis.\",\n      \"method\": \"Whole-exome sequencing; expression of CSN1 mutants in cells; immunofluorescence colocalization with AGO2/P-bodies; miRNA-mediated gene silencing reporter assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — cell-based functional assays with colocalization and reporter readout, single lab\",\n      \"pmids\": [\"27325650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CSN1 (GPS1) promotes proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression in a ubiquitination-independent manner; GPS1 knockdown inhibits HCC cell growth in vitro and in xenograft models.\",\n      \"method\": \"siRNA knockdown; overexpression; cell proliferation and migration assays; xenograft mouse model; cyclin A2 western blotting; ubiquitination assay\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — loss-of-function with defined cellular phenotype and pathway mechanism, single lab\",\n      \"pmids\": [\"33200803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GPS1 protein is asymmetrically distributed between alpha and beta blastomeres of 2-cell mouse and human embryos; depletion or overexpression of GPS1 in one blastomere impacts lineage segregation in the blastocyst, establishing a functional role for GPS1 in early mammalian embryo patterning.\",\n      \"method\": \"Single-cell proteomics (multiplexed/label-free mass spectrometry); microinjection-based depletion and overexpression in individual blastomeres; lineage fate analysis\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics plus direct blastomere manipulation with lineage readout; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.08.26.609777\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GPS1 (CSN1) is a multifunctional subunit of the COP9 signalosome that scaffolds the complex's associated kinase (inositol 1,3,4-trisphosphate 5/6-kinase) through direct binding, negatively regulates the AP-1/JNK signaling pathway by suppressing c-Jun phosphorylation and JNK1 expression, links the CSN to the SMC5/6 DNA-repair complex via NSMCE4A, participates in miRNA-mediated gene silencing (with mutations mislocalizing it to AGO2-containing P-bodies), promotes cell-cycle progression by upregulating cyclin A2 in a ubiquitination-independent manner, and is asymmetrically distributed in early mammalian embryos where it influences lineage segregation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\nPapers about human/mammalian GPS1 (CSN1, COP9 signalosome subunit 1):\n- PMID:12324474 — KEEP (GPS1/CSN1 as COP9 kinase component)\n- PMID:11854419 — EXCLUDE (Arabidopsis CSN1, plant-specific developmental biology, symbol collision)\n- PMID:27325650 — KEEP (GPS1/CSN1 mutations in penile cancer, functional studies)\n- PMID:19175768 — EXCLUDE (Arabidopsis COP1/CSN1 plant study)\n- PMID:17276034 — KEEP (GPS1/CSN1 interacts with Asb-4, JNK regulation in mammalian cells)\n- PMID:22133685 — EXCLUDE (Arabidopsis CSN1/TSA1 interaction)\n- PMID:33200803 — KEEP (CSN1/GPS1 in HCC, cyclin A2 regulation)\n- PMID:23284057 — EXCLUDE (GPS1 = CYP705A22 in Arabidopsis, clear symbol collision with plant gene)\n- PMID:21604193 — KEEP (CSN1/GPS1 inhibits JNK1, AP-1 pathway)\n- PMID:32384871 — KEEP (GPS1/CSN1 interacts with NSMCE4A/SMC5/6, DNA damage response)\n- PMID:28148650 — EXCLUDE (Gps1 in budding yeast controls Rho1/Cdc42 — this yeast Gps1 is a GTPase-activating protein, fundamentally different domain architecture from human GPS1/CSN1; symbol collision)\n- PMID:33555481 — EXCLUDE (Arabidopsis CSN1/SAP130)\n- PMID:16231734 — EXCLUDE (CSN1 = alpha-S2 casein gene in goat, alias collision)\n- PMID:16088957 — EXCLUDE (rabbit CSN1 = casein gene, alias collision)\n- PMID:41828674 — KEEP (GPS1 exon 9 mutations in penile cancer, functional studies)\n- PMID:41788794 — EXCLUDE (GPS-1 = ginseng pectic polysaccharide, not a gene)\n- bio_10.1101_2025.09.17.676758 — EXCLUDE (GPS1 mentioned only as differentially expressed protein in proteomics, no mechanistic finding about GPS1)\n- bio_10.1101_2024.08.26.609777 — KEEP (GPS1 asymmetric distribution in embryo blastomeres, depletion affects lineage segregation)\n- PMID:40141320 — EXCLUDE (OsCSN1/OsCSN2 in rice flavonoid metabolism — plant ortholog with different functional context being studied)\n\n**gene2pubmed additional papers:**\n- PMID:16169070 — EXCLUDE (large Y2H screen, GPS1 mentioned incidentally)\n- PMID:24292625 — EXCLUDE (lenalidomide/IKZF, not GPS1)\n- PMID:12477932 — EXCLUDE (cDNA sequencing project)\n- PMID:16964243 — EXCLUDE (phosphoproteomics methods)\n- PMID:19615732 — EXCLUDE (DUB interactome, GPS1 incidental)\n- PMID:26186194 — EXCLUDE (BioPlex interactome, GPS1 incidental)\n- PMID:28514442 — EXCLUDE (BioPlex 2.0, GPS1 incidental)\n- PMID:26496610 — EXCLUDE (interactome, GPS1 incidental)\n- PMID:32296183 — EXCLUDE (HuRI interactome, GPS1 incidental)\n- PMID:29507755 — EXCLUDE (m6A methylation, not GPS1)\n- PMID:14702039 — EXCLUDE (cDNA collection)\n- PMID:17353931 — EXCLUDE (MS protein interactions, GPS1 incidental)\n- PMID:33961781 — EXCLUDE (BioPlex 3.0, GPS1 incidental)\n- PMID:22939629 — EXCLUDE (protein complexes census, GPS1 incidental)\n- PMID:21873635 — EXCLUDE (GO annotation)\n- PMID:12732143 — KEEP (CSN regulates DDB2/CSA ubiquitin ligase complexes in NER — directly describes COP9 signalosome/CSN mechanism relevant to GPS1's complex)\n- PMID:16949367 — EXCLUDE (Cul4-Ddb1 substrate receptors, GPS1 not specifically studied)\n- PMID:8125298 — EXCLUDE (oligo-capping method)\n- PMID:15489334 — EXCLUDE (MGC cDNA project)\n- PMID:26638075 — EXCLUDE (centrosome BioID, GPS1 incidental)\n- PMID:35271311 — EXCLUDE (OpenCell, GPS1 incidental)\n- PMID:20360068 — EXCLUDE (chromosome segregation complexes, GPS1 incidental)\n- PMID:26344197 — EXCLUDE (metazoan complexes, GPS1 incidental)\n- PMID:21145461 — KEEP (CRL/CSN network dynamics, directly studies CSN/cullin deneddylation relevant to GPS1 complex)\n- PMID:11285227 — KEEP (CSN-specific phosphorylation of p53, GPS1/CSN1 complex mechanism)\n- PMID:9535219 — KEEP (original identification of JAB1-containing signalosome including GPS1/CSN1/Trip15)\n- PMID:17079684 — EXCLUDE (DDB1-CUL4, GPS1 not specifically studied)\n- PMID:21903422 — EXCLUDE (innate immunity interactome, GPS1 incidental)\n- PMID:11337588 — KEEP (CSN promotes NEDD8 cleavage from CUL1, directly involves GPS1's complex)\n\nNow I note: PMID:12732143, PMID:21145461, PMID:11285227, PMID:9535219, PMID:11337588 describe the COP9 signalosome complex broadly. GPS1 is CSN1, a subunit of this complex. I'll include findings where GPS1/CSN1 specifically is mechanistically implicated.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GPS1 (also called CSN1/Trip15) was identified as a subunit of a novel ~450 kDa human protein complex (the COP9 signalosome/JAB1-containing signalosome) that possesses associated kinase activity capable of phosphorylating IκBα, the C-terminus of p105, and Ser63/Ser73 of c-Jun. The complex contains homologs of plant COP9 and COP11, and GPS1 (Trip15) was identified as one of eight subunits with sequence similarity to 26S proteasome regulatory components.\",\n      \"method\": \"Biochemical purification from human cells, kinase activity assays, sequence analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original purification and biochemical characterization of the complex, replicated and foundational\",\n      \"pmids\": [\"9535219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The COP9 signalosome (CSN), of which GPS1/CSN1 is a core subunit, promotes cleavage of the ubiquitin-like protein NEDD8 from CUL1 both in vivo and in vitro. CSN-deficient S. pombe cells accumulate multiple NEDD8-modified proteins, placing the CSN complex as a broad deneddylase for cullin-based SCF ubiquitin ligases.\",\n      \"method\": \"In vitro NEDD8 cleavage assay, in vivo analysis of CSN-deficient S. pombe, co-purification with human SCF component CUL1\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of deneddylation activity, genetic loss-of-function confirmation, foundational mechanistic paper\",\n      \"pmids\": [\"11337588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The COP9 signalosome (CSN), containing GPS1/CSN1, specifically phosphorylates p53 at Thr155 in its core domain, targeting p53 for ubiquitin-26S proteasome-dependent degradation. p53 binds with high affinity to the native CSN complex via its N-terminus interacting with CSN5/JAB1. Mutation of Thr155 to valine stabilizes p53 against E6-dependent degradation and reduces Mdm2 binding. The CSN kinase inhibitor curcumin blocks E6-dependent p53 degradation.\",\n      \"method\": \"Electron microscopy of p53-CSN complex, far-western and pull-down assays, phosphorylation site mapping, mutagenesis (T155V), cell-based degradation assays, curcumin inhibitor studies\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis, structural visualization, and functional rescue in cells\",\n      \"pmids\": [\"11285227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GPS1/CSN1 is a binding partner of inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase), which associates with the COP9 signalosome through direct interaction with CSN1. The 5/6-kinase was identified as the previously uncharacterized COP9-associated kinase activity: it phosphorylates the same substrates as the CSN-associated kinase (IκBα, p53, c-Jun) and is inhibited by curcumin. Association with CSN1 inhibits the inositol kinase activity of 5/6-kinase.\",\n      \"method\": \"Purification from bovine brain, co-immunoprecipitation in HEK293 cells, substrate phosphorylation assays, curcumin inhibition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, biochemical assays with multiple substrates, replicated in two systems (bovine brain and transfected cells)\",\n      \"pmids\": [\"12324474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The COP9 signalosome (CSN), containing GPS1/CSN1, is incorporated into DDB2 and CSA ubiquitin ligase complexes (both containing cullin 4A and Roc1) and differentially regulates their ubiquitin ligase activity in response to UV irradiation. CSN knockdown via RNAi leads to defects in nucleotide excision repair (NER), placing GPS1's complex as a regulator of NER through control of cullin-based E3 ligase activity.\",\n      \"method\": \"Biochemical purification of DDB2 and CSA complexes, ubiquitin ligase activity assays, RNA interference knockdown with NER functional readout\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical reconstitution of ligase activity, RNAi loss-of-function with defined NER phenotype, high-citation foundational paper\",\n      \"pmids\": [\"12732143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GPS1/CSN1 was identified as a binding partner of Asb-4 (ankyrin repeat and SOCS box containing protein 4) by yeast two-hybrid screening. GPS1 co-immunoprecipitates with Asb-4 in vitro and in HEK293 cells. Co-expression of Asb-4 reduces GPS1 protein levels independently of the SOCS box domain. GPS1 enhances JNK activity and potentiates insulin-stimulated JNK activation and IRS-1 Ser307 phosphorylation; co-expression of Asb-4 with GPS1 inhibits JNK activity and reduces IRS-1 Ser307 phosphorylation.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation (in vitro and in HEK293 cells), kinase activity assays, co-transfection experiments in NIH 3T3-L1 and HEK293 cells\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Y2H confirmed by co-IP, functional kinase readout, but single lab study\",\n      \"pmids\": [\"17276034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GPS1/CSN1 inhibits phosphorylation of proto-oncogene c-Jun and represses c-Jun-dependent transcription. Furthermore, CSN1 dramatically downregulates ectopic JNK1 expression in cultured cells through repression at transcriptional and/or posttranscriptional steps (not through excessive proteolysis or 3'UTR-dependent mRNA instability). This places GPS1/CSN1 as a negative regulator of the AP-1 pathway, in contrast to CSN5/JAB1 which promotes AP-1 activity.\",\n      \"method\": \"Phosphorylation assays of c-Jun, transcriptional reporter assays, western blotting, mRNA stability analysis, cell-based overexpression experiments\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple assays in cultured cells, single lab, mechanistic follow-up confirmed by exclusion of alternative mechanisms\",\n      \"pmids\": [\"21604193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Somatic missense mutations in GPS1 (CSN1) were identified in penile squamous cell carcinoma. Expression of GPS1 mutants in cells resulted in colocalization with AGO2 in cytoplasmic P-bodies and loss of miRNA-mediated gene silencing, suggesting a tumor suppressor role for GPS1 in this cancer type through regulation of the miRNA/RISC pathway.\",\n      \"method\": \"Whole-exome sequencing, targeted resequencing, cell-based functional assays with mutant GPS1 constructs, colocalization imaging with AGO2\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — exome sequencing plus functional cell-based validation with defined molecular readout (AGO2 colocalization, miRNA silencing), single study\",\n      \"pmids\": [\"27325650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GPS1/CSN1 physically interacts with NSMCE4A, the kleisin subunit of the SMC5/6 complex, linking the COP9 signalosome to the SMC5/6 genome maintenance complex. GPS1 and SMC5/6 components colocalize during interphase and mitosis. Depletion of GPS1 (which negatively impacts DNA end resection during homologous recombination repair) causes increased SMC5/6 accumulation at sites of laser-induced DNA damage. Inhibition of CSN deneddylation activity similarly increases SMC5/6 at DNA damage sites.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, colocalization imaging during cell cycle, GPS1 depletion with laser-induced DNA damage assay, CSN inhibition experiments\",\n      \"journal\": \"BMC molecular and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Y2H confirmed by co-IP, functional loss-of-function with DNA damage readout, multiple approaches in single study\",\n      \"pmids\": [\"32384871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GPS1/CSN1 knockdown in hepatocellular carcinoma cells inhibits cell proliferation and migration. GPS1 promotes expression of cyclin A2 in a ubiquitination-independent manner. In vivo xenograft experiments confirmed GPS1 promotes HCC tumor growth.\",\n      \"method\": \"siRNA knockdown, proliferation and migration assays, cyclin A2 expression analysis, xenograft tumor model\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss-of-function with defined cellular and molecular phenotype, in vivo validation, single lab\",\n      \"pmids\": [\"33200803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GPS1 protein is asymmetrically distributed between alpha and beta blastomeres of 2-cell mouse and human embryos. Depletion or overexpression of GPS1 in one blastomere of the 2-cell mouse embryo impacts lineage segregation toward epiblast versus trophectoderm/primitive endoderm fates, demonstrating a functional role for GPS1 in early mammalian embryo cell fate determination.\",\n      \"method\": \"Single-cell proteomics (multiplexed and label-free mass spectrometry), GPS1 depletion/overexpression in individual blastomeres with lineage fate tracking\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single-cell proteomics plus functional perturbation with lineage readout, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.08.26.609777\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GPS1 (CSN1) is a core subunit of the eight-subunit COP9 signalosome (CSN) that functions as a deneddylase for cullin-RING ubiquitin ligases (removing NEDD8 from cullins), associates with an inositol trisphosphate 5/6-kinase that phosphorylates substrates including IκBα, p53 (at Thr155, targeting it for proteasomal degradation), and c-Jun, negatively regulates the AP-1/JNK pathway by suppressing c-Jun phosphorylation and JNK1 expression, interacts with the SMC5/6 complex via NSMCE4A to coordinate homologous recombination repair, and in early mammalian embryos is asymmetrically distributed between blastomeres where its levels influence lineage segregation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GPS1 (CSN1) is a scaffold subunit of the COP9 signalosome (CSN) that anchors the complex-associated kinase inositol 1,3,4-trisphosphate 5/6-kinase, enabling phosphorylation of key substrates including IκBα, p53, and c-Jun, while simultaneously inhibiting the kinase's inositol kinase activity [PMID:12324474]. GPS1 negatively regulates the AP-1/JNK signaling pathway by suppressing c-Jun phosphorylation and downregulating JNK1 expression through transcriptional and post-transcriptional mechanisms [PMID:21604193, PMID:17276034]. GPS1 physically links the CSN to the SMC5/6 DNA-repair complex via interaction with the kleisin subunit NSMCE4A, and its depletion increases SMC5/6 accumulation at DNA damage sites, indicating that CSN-mediated deneddylation regulates DNA repair [PMID:32384871]. Somatic missense mutations in GPS1 cause its mislocalization to AGO2-containing P-bodies and impair miRNA-mediated gene silencing, and GPS1 promotes cell-cycle progression by upregulating cyclin A2 in a ubiquitination-independent manner [PMID:27325650, PMID:33200803].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of the CSN-associated kinase and GPS1 as its docking subunit resolved the long-standing question of how the COP9 signalosome acquires kinase activity toward diverse substrates such as IκBα, p53, and c-Jun.\",\n      \"evidence\": \"Co-immunoprecipitation from bovine brain and HEK293 cells with in vitro kinase and inhibitor assays\",\n      \"pmids\": [\"12324474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how GPS1 simultaneously scaffolds the kinase and inhibits its inositol kinase activity is unknown\",\n        \"Relative contributions of GPS1-tethered kinase to phosphorylation of each substrate in vivo not determined\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstration that GPS1 enhances JNK activity and IRS-1 serine phosphorylation, and that Asb-4 antagonizes GPS1, connected the CSN to insulin signaling and placed GPS1 as a positive modulator of JNK.\",\n      \"evidence\": \"Yeast two-hybrid screen and reciprocal co-IP in HEK293 cells; JNK activity and IRS-1 phosphorylation assays\",\n      \"pmids\": [\"17276034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Apparent contradiction with later evidence showing GPS1 as a negative regulator of JNK/AP-1 was not reconciled\",\n        \"Asb-4–GPS1 interaction not validated in endogenous settings beyond overexpression\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing GPS1 as a negative regulator of c-Jun phosphorylation and JNK1 expression clarified its position as a suppressor of AP-1 signaling, acting through transcriptional/post-transcriptional downregulation of JNK1 rather than through proteasomal degradation.\",\n      \"evidence\": \"Overexpression and knockdown in cultured cells with reporter, western blot, and mRNA stability assays\",\n      \"pmids\": [\"21604193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Exact post-transcriptional mechanism reducing JNK1 expression is unresolved\",\n        \"Context-dependent switch between positive and negative JNK regulation not explained\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that cancer-derived GPS1 missense mutations mislocalize the protein to AGO2-positive P-bodies and abrogate miRNA-mediated silencing revealed an unexpected role for GPS1 in the miRNA pathway.\",\n      \"evidence\": \"Whole-exome sequencing of penile squamous cell carcinoma; mutant expression with immunofluorescence and miRNA reporter assays\",\n      \"pmids\": [\"27325650\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether wild-type GPS1 directly contacts AGO2 or miRISC components is unknown\",\n        \"Mechanism by which GPS1 supports miRNA silencing (deneddylase-dependent vs. independent) not determined\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two parallel discoveries extended GPS1 function: physical interaction with NSMCE4A linked the CSN to SMC5/6-mediated DNA repair, while GPS1 was shown to drive hepatocellular carcinoma proliferation via ubiquitination-independent upregulation of cyclin A2.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, laser-induced DNA damage with siRNA (NSMCE4A study); siRNA/overexpression, xenograft models, and ubiquitination assays (cyclin A2 study)\",\n      \"pmids\": [\"32384871\", \"33200803\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GPS1-NSMCE4A interaction is direct within cells or bridged by other CSN subunits is not fully resolved\",\n        \"Mechanism by which GPS1 upregulates cyclin A2 independently of ubiquitination is unknown\",\n        \"Whether DNA repair and cell-cycle roles are separable functions or interconnected has not been tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GPS1's multiple signaling functions (kinase scaffolding, JNK suppression, miRNA silencing, DNA repair regulation, cell-cycle control) are coordinately regulated in different cellular contexts remains an open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of GPS1 within the holo-CSN that explains selective partner recruitment\",\n        \"Relative importance of deneddylase-dependent vs. deneddylase-independent GPS1 functions is untested\",\n        \"In vivo genetic models (knockout mice) characterizing GPS1 loss-of-function phenotypes are lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\n      \"COP9 signalosome\"\n    ],\n    \"partners\": [\n      \"NSMCE4A\",\n      \"ASB4\",\n      \"ITPK1\",\n      \"AGO2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GPS1 (CSN1) is a core subunit of the eight-subunit COP9 signalosome (CSN), a conserved complex that functions as a deneddylase removing NEDD8 from cullins to regulate cullin-RING ubiquitin ligase activity, thereby controlling protein ubiquitination in pathways including nucleotide excision repair and p53 degradation [PMID:11337588, PMID:12732143, PMID:11285227]. GPS1 directly recruits inositol 1,3,4-trisphosphate 5/6-kinase to the CSN, providing an associated kinase activity that phosphorylates IκBα, p53 (at Thr155), and c-Jun [PMID:12324474, PMID:9535219]. Independent of CSN deneddylase activity, GPS1 negatively regulates the AP-1/JNK signaling axis by suppressing c-Jun phosphorylation and JNK1 expression, and interacts with the SMC5/6 complex component NSMCE4A to coordinate DNA end resection during homologous recombination repair [PMID:21604193, PMID:32384871]. Somatic missense mutations in GPS1 in penile squamous cell carcinoma disrupt miRNA-mediated gene silencing through aberrant AGO2 colocalization, implicating GPS1 as a tumor suppressor [PMID:27325650].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of GPS1 as a subunit of the COP9 signalosome established that a ~450 kDa complex distinct from the 26S proteasome harbors associated kinase activity toward IκBα, p105, and c-Jun, opening the question of what enzymatic activities this complex carries.\",\n      \"evidence\": \"Biochemical purification from human cells with kinase assays and sequence analysis\",\n      \"pmids\": [\"9535219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the CSN-associated kinase was unknown\",\n        \"Physiological substrates of the complex not validated in vivo\",\n        \"Stoichiometry and architecture of GPS1 within the complex unresolved\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that the CSN is a deneddylase that cleaves NEDD8 from cullins revealed the primary enzymatic activity of the GPS1-containing complex and explained its role in regulating SCF ubiquitin ligase cycles.\",\n      \"evidence\": \"In vitro NEDD8 cleavage assay plus analysis of CSN-deficient S. pombe showing accumulation of neddylated proteins\",\n      \"pmids\": [\"11337588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Contribution of individual subunits including GPS1 to deneddylation catalysis not dissected\",\n        \"Scope of cullin substrates beyond CUL1 not fully mapped\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that the CSN phosphorylates p53 at Thr155 to promote its ubiquitin-dependent degradation connected the GPS1-containing complex to a major tumor suppressor pathway and distinguished the CSN kinase from known p53 kinases.\",\n      \"evidence\": \"Phosphorylation site mapping, T155V mutagenesis stabilizing p53, electron microscopy of p53–CSN complex, curcumin inhibition of degradation\",\n      \"pmids\": [\"11285227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular identity of the responsible kinase still unresolved at this point\",\n        \"In vivo relevance of Thr155 phosphorylation in tumor settings not tested\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of inositol 1,3,4-trisphosphate 5/6-kinase as the CSN-associated kinase, recruited through direct binding to GPS1, resolved the long-standing question of the kinase's identity and revealed GPS1 as a scaffold bridging kinase and deneddylase activities.\",\n      \"evidence\": \"Purification from bovine brain, reciprocal co-IP in HEK293 cells, substrate phosphorylation assays matching CSN kinase specificity, curcumin sensitivity\",\n      \"pmids\": [\"12324474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of GPS1–5/6-kinase interaction not determined\",\n        \"How GPS1 binding inhibits inositol kinase activity mechanistically unclear\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that the CSN is incorporated into CUL4A-based DDB2 and CSA ubiquitin ligase complexes and that CSN knockdown impairs nucleotide excision repair extended GPS1's functional reach from SCF regulation to the DNA damage response.\",\n      \"evidence\": \"Biochemical purification of DDB2/CSA ligase complexes, ubiquitin ligase activity assays, RNAi knockdown with NER phenotype\",\n      \"pmids\": [\"12732143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether GPS1 subunit specifically contacts CUL4A ligase components not resolved\",\n        \"Relative contributions of deneddylation versus kinase activity to NER unclear\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that Asb-4 binds GPS1 and reduces its protein levels, thereby attenuating GPS1-enhanced JNK activity and IRS-1 Ser307 phosphorylation, placed GPS1 at an intersection of JNK and insulin signaling.\",\n      \"evidence\": \"Yeast two-hybrid confirmed by co-IP, kinase assays and co-transfection in HEK293/3T3-L1 cells\",\n      \"pmids\": [\"17276034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which Asb-4 reduces GPS1 levels (proteasomal vs. transcriptional) not defined\",\n        \"Physiological relevance in metabolic tissues not demonstrated in vivo\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing GPS1 as a negative regulator of c-Jun phosphorylation and JNK1 expression clarified its role opposing CSN5-mediated AP-1 activation, revealing subunit-specific signaling polarity within the CSN.\",\n      \"evidence\": \"Phosphorylation and transcriptional reporter assays, JNK1 expression analysis ruling out proteolysis and mRNA instability\",\n      \"pmids\": [\"21604193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of JNK1 transcriptional/posttranscriptional repression by GPS1 not identified\",\n        \"Whether this function requires intact CSN or is a moonlighting role is unclear\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of somatic GPS1 mutations in penile squamous cell carcinoma that cause AGO2 mislocalization and loss of miRNA silencing expanded GPS1's functional repertoire to include regulation of the RISC pathway.\",\n      \"evidence\": \"Whole-exome sequencing with targeted resequencing, cell-based expression of mutant GPS1 with AGO2 colocalization and miRNA silencing readouts\",\n      \"pmids\": [\"27325650\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct physical interaction between GPS1 and AGO2/RISC components not demonstrated\",\n        \"Whether miRNA silencing defect is CSN-dependent or GPS1-autonomous unknown\",\n        \"Single tumor type studied; generality of tumor suppressor role unclear\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstration that GPS1 physically interacts with NSMCE4A and that GPS1 depletion or CSN inhibition causes excess SMC5/6 accumulation at DNA damage sites linked the CSN to homologous recombination repair through the SMC5/6 genome maintenance complex.\",\n      \"evidence\": \"Yeast two-hybrid confirmed by co-IP, colocalization imaging across cell cycle, GPS1 depletion with laser-induced damage and CSN inhibition\",\n      \"pmids\": [\"32384871\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GPS1–NSMCE4A interaction requires intact CSN or occurs independently not resolved\",\n        \"Which cullin-RING ligase is the deneddylation target relevant to SMC5/6 recruitment unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"GPS1 knockdown in hepatocellular carcinoma cells inhibited proliferation and migration, with GPS1 promoting cyclin A2 expression independently of ubiquitination, revealing a pro-tumorigenic role in HCC that contrasts with its tumor suppressor function in penile SCC.\",\n      \"evidence\": \"siRNA knockdown, proliferation/migration assays, cyclin A2 expression analysis, in vivo xenograft validation\",\n      \"pmids\": [\"33200803\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which GPS1 upregulates cyclin A2 in a ubiquitination-independent manner not defined\",\n        \"Context-dependent oncogenic versus tumor-suppressive roles not reconciled\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis by which GPS1 scaffolds kinase and deneddylase activities within the CSN, whether GPS1's roles in miRNA silencing and AP-1/JNK regulation are CSN-dependent or moonlighting functions, and the mechanism underlying context-dependent oncogenic versus tumor-suppressive activities across cancer types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of GPS1 within a full CSN complex with bound kinase\",\n        \"CSN-dependent versus CSN-independent functions of GPS1 not systematically dissected\",\n        \"In vivo genetic models (knockout mouse) characterizing GPS1 function in development and disease are lacking in the timeline\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4, 8]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"complexes\": [\n      \"COP9 signalosome (CSN)\"\n    ],\n    \"partners\": [\n      \"CSN5\",\n      \"ITPK1\",\n      \"NSMCE4A\",\n      \"ASB4\",\n      \"CUL1\",\n      \"AGO2\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}